Report Detail

Pharma & Healthcare Global Alectinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3557471
  • |
  • 26 June, 2019
  • |
  • Global
  • |
  • 107 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Alectinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Alectinib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Everest Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
150mg*140 Capsules
150mg*28 Capsules
20mg*1 Capsule
40mg*1 Capsule
150mg*26 Capsules

Market Segment by Applications, can be divided into
Unresectable NSCLC
Advanced NSCLC
Recurrent NSCLC
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alectinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alectinib, with price, sales, revenue and global market share of Alectinib in 2017 and 2018.
Chapter 3, the Alectinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alectinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Alectinib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Alectinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Alectinib Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 150mg*140 Capsules
      • 1.2.2 150mg*28 Capsules
      • 1.2.3 20mg*1 Capsule
      • 1.2.4 40mg*1 Capsule
      • 1.2.5 150mg*26 Capsules
    • 1.3 Market Analysis by Applications
      • 1.3.1 Unresectable NSCLC
      • 1.3.2 Advanced NSCLC
      • 1.3.3 Recurrent NSCLC
      • 1.3.4 Other
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Alectinib Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Everest Pharmaceuticals
      • 2.2.1 Business Overview
      • 2.2.2 Alectinib Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Everest Pharmaceuticals Alectinib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Alectinib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Alectinib Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Alectinib Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Alectinib Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Alectinib Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Alectinib Market Analysis by Regions

    • 4.1 Global Alectinib Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Alectinib Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Alectinib Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Alectinib Sales and Growth Rate (2014-2019)
    • 4.3 Europe Alectinib Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Alectinib Sales and Growth Rate (2014-2019)
    • 4.5 South America Alectinib Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Alectinib Sales and Growth Rate (2014-2019)

    5 North America Alectinib by Country

    • 5.1 North America Alectinib Sales, Revenue and Market Share by Country
      • 5.1.1 North America Alectinib Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Alectinib Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Alectinib Sales and Growth Rate (2014-2019)
    • 5.3 Canada Alectinib Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Alectinib Sales and Growth Rate (2014-2019)

    6 Europe Alectinib by Country

    • 6.1 Europe Alectinib Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Alectinib Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Alectinib Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Alectinib Sales and Growth Rate (2014-2019)
    • 6.3 UK Alectinib Sales and Growth Rate (2014-2019)
    • 6.4 France Alectinib Sales and Growth Rate (2014-2019)
    • 6.5 Russia Alectinib Sales and Growth Rate (2014-2019)
    • 6.6 Italy Alectinib Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Alectinib by Country

    • 7.1 Asia-Pacific Alectinib Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Alectinib Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Alectinib Revenue and Market Share by Country (2014-2019)
    • 7.2 China Alectinib Sales and Growth Rate (2014-2019)
    • 7.3 Japan Alectinib Sales and Growth Rate (2014-2019)
    • 7.4 Korea Alectinib Sales and Growth Rate (2014-2019)
    • 7.5 India Alectinib Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Alectinib Sales and Growth Rate (2014-2019)

    8 South America Alectinib by Country

    • 8.1 South America Alectinib Sales, Revenue and Market Share by Country
      • 8.1.1 South America Alectinib Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Alectinib Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Alectinib Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Alectinib Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Alectinib Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Alectinib by Countries

    • 9.1 Middle East and Africa Alectinib Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Alectinib Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Alectinib Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Alectinib Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Alectinib Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Alectinib Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Alectinib Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Alectinib Sales and Growth Rate (2014-2019)

    10 Global Alectinib Market Segment by Type

    • 10.1 Global Alectinib Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Alectinib Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Alectinib Revenue and Market Share by Type (2014-2019)
    • 10.2 150mg*140 Capsules Sales Growth and Price
      • 10.2.1 Global 150mg*140 Capsules Sales Growth (2014-2019)
      • 10.2.2 Global 150mg*140 Capsules Price (2014-2019)
    • 10.3 150mg*28 Capsules Sales Growth and Price
      • 10.3.1 Global 150mg*28 Capsules Sales Growth (2014-2019)
      • 10.3.2 Global 150mg*28 Capsules Price (2014-2019)
    • 10.4 20mg*1 Capsule Sales Growth and Price
      • 10.4.1 Global 20mg*1 Capsule Sales Growth (2014-2019)
      • 10.4.2 Global 20mg*1 Capsule Price (2014-2019)
    • 10.5 40mg*1 Capsule Sales Growth and Price
      • 10.5.1 Global 40mg*1 Capsule Sales Growth (2014-2019)
      • 10.5.2 Global 40mg*1 Capsule Price (2014-2019)
    • 10.6 150mg*26 Capsules Sales Growth and Price
      • 10.6.1 Global 150mg*26 Capsules Sales Growth (2014-2019)
      • 10.6.2 Global 150mg*26 Capsules Price (2014-2019)

    11 Global Alectinib Market Segment by Application

    • 11.1 Global Alectinib Sales Market Share by Application (2014-2019)
    • 11.2 Unresectable NSCLC Sales Growth (2014-2019)
    • 11.3 Advanced NSCLC Sales Growth (2014-2019)
    • 11.4 Recurrent NSCLC Sales Growth (2014-2019)
    • 11.5 Other Sales Growth (2014-2019)

    12 Alectinib Market Forecast (2019-2024)

    • 12.1 Global Alectinib Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Alectinib Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Alectinib Market Forecast (2019-2024)
      • 12.2.2 Europe Alectinib Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Alectinib Market Forecast (2019-2024)
      • 12.2.4 South America Alectinib Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Alectinib Market Forecast (2019-2024)
    • 12.3 Alectinib Market Forecast by Type (2019-2024)
      • 12.3.1 Global Alectinib Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Alectinib Market Share Forecast by Type (2019-2024)
    • 12.4 Alectinib Market Forecast by Application (2019-2024)
      • 12.4.1 Global Alectinib Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Alectinib Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Alectinib . Industry analysis & Market Report on Alectinib is a syndicated market report, published as Global Alectinib Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Alectinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,738.76
      4,108.14
      5,477.52
      3,215.52
      4,823.28
      6,431.04
      545,977.20
      818,965.80
      1,091,954.40
      289,884.00
      434,826.00
      579,768.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report